팝업레이어 알림

팝업레이어 알림이 없습니다.

Create health, happy lives and beautiful future

EDGC is at the center of the revolution beginning to disappear a border between industries as technologies converge.

  • Help to maintain healthy pregnancy by analyzing fetal chromosomal abnormalities.
  • Detect chromosomal abnormalities a baby may have.
  • Parents can take care of children’s health with proper treatment of analyzing their genes.
  • Analyze the genetic risk of diseases to help prevent them in advance.

Genetic Analysis Service Throughout the Life Cycle

  • What does
    your DNA look like?

    MIT Technology Review paid attention to
    ‘Genetic Fortune Telling’ in ’10 Breakthrough Technologies 2018’.
    Genes have all the information you may wish to know.
    Your genes exactly know your weaknesses, personality, aptitude and even the most effective exercises for you.
    Start to prepare for the era of the healthy 100-year life through genetic analysis.

  • EDGC is
    a global healthcare
    company.

    EDGC analyzes your genes based on
    cutting-edge genetic analysis technology and bioinformatics technology and suggests personalized lifestyle to help prevent diseases.

Business

EDGC Service

  • Non-Invasive Prenatal Test

    NICE®

    NICE® test, which has been verified its accuracy and reliability by acquiring CLIA and CAP certificates, detects fetal chromosomal abnormalities safely and easily.

  • Newborn Genetic Screening Test

    bebegene®

    bebegene® which detects chromosomal abnormalities such as major genetic diseases, Wilson’s Disease, ADHD, hearing loss and so on is the first test for a precious baby.

  • Integrated Genotype and Phenotype Test

    MYGENPLAN®

    MYGENPLAN® is the first integrated test in South Korea which analyzes metabolic genes and biological age and suggests personalized healthcare guide.

  • Cancer and General Disease Prediction Test

    gene2me® Plus

    gene2me® Plus predicts the genetic risk of major cancer, general diseases and eye diseases, and designs healthy future with early personalized treatment.

Recent News

EDGC Recent News

Article

 Korean genome analyzing firm EDGC and two Chinese universities will conduct joint research into cancer-detecting liquid biopsy and launch the service in China this year.EDGC, one of the industry's global leaders ― based in Songdo, Incheon ― signed the partnership with Capital Medical University in Beijing and the Fudan University Shanghai Cancer Center on Jan. 7.The three agreed to complete the research project in the first half of this year, pass China's National Medical Products Administration screening and launch the service in China before the end of the year.Liquid biopsy, which can detect cancer in its early stages, has been tested by genome sequencing companies worldwide, including the United States' GRAIL and EDGC leading the Asian market, according to the Korean firm's foreign research and development business team leader Lee Jeong-nam."Following the successful completion of this joint research, we will launch the service in the Chinese market this year and also other Asian countries as early as possible, enabling early prognosis of cancer," Lee told The Korea Times.EDGC has developed the prognosis method using gene sequencing that can detect cancerous cell-bound circulating tumor DNA (ctDNA) hidden in circulating free DNA (cfDNA) in blood. The company said the technology was considered almost impossible to achieve only three to four years ago.Capital Medical University, having one of China's five largest general hospitals, will provide the joint team with medical equipment and professional support. Fudan cancer center in April 2019 started research cooperation on whole genome sequencing with American biotech firm Illumina, proving its quality assets in genome sequencing. 

2020.01.17

Global Network

EONE-DIAGNOMICS GENOME CENTER

EDGC Promotion Video

No posts found.